Treatment with Histone Deacetylase Inhibitors Creates 'BRCAness' and Sensitizes Human Triple Negative Breast Cancer Cells to PARP Inhibitors and Cisplatin

被引：6
|
作者：
Bhalla, K. N. [1 ]
Rao, R. [1 ]
Sharma, P. [1 ]
Das Gupta, S. [1 ]
Chauhan, L. [1 ]
Stecklein, S. [1 ]
Fiskus, W. [1 ]
机构：
[1] Univ Kansas, Ctr Canc, Kansas City, KS USA
来源：
CANCER RESEARCH | 2012年 / 72卷
关键词：
D O I：
10.1158/0008-5472.SABCS12-S3-7
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
S3-7
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
    Danqi Chen
    Aijun Shen
    Guanghua Fang
    Hongchun Liu
    Minmin Zhang
    Shuai Tang
    Bing Xiong
    Lanping Ma
    Meiyu Geng
    Jingkang Shen
    ActaPharmaceuticaSinicaB, 2016, 6 (01) : 93 - 99
  • [42] Tetrahydroisoquinolines as novel histone deacetylase inhibitors for treatment of cancer
    Chen, Danqi
    Shen, Aijun
    Fang, Guanghua
    Liu, Hongchun
    Zhang, Minmin
    Tang, Shuai
    Xiong, Bing
    Ma, Lanping
    Geng, Meiyu
    Shen, Jingkang
    ACTA PHARMACEUTICA SINICA B, 2016, 6 (01) : 93 - 99
  • [43] Histone deacetylase inhibitors in the treatment of cancer: overview and perspectives
    Giannini, Giuseppe
    Cabri, Walter
    Fattorusso, Caterina
    Rodriquez, Manuela
    FUTURE MEDICINAL CHEMISTRY, 2012, 4 (11) : 1439 - 1460
  • [44] Potential of histone deacetylase inhibitors for bladder cancer treatment
    Tanji, Nozomu
    Ozawa, Akira
    Kikugawa, Tadahiko
    Miura, Noriyoshi
    Sasaki, Toyokazu
    Azuma, Kouji
    Yokoyama, Masayoshi
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (06) : 959 - 965
  • [45] Histone Deacetylase Inhibitors: Novel Agents in Cancer Treatment
    Glass, Erica
    Viale, Pamela Hallquist
    CLINICAL JOURNAL OF ONCOLOGY NURSING, 2013, 17 (01) : 34 - 40
  • [46] Histone Deacetylase Inhibitors and Phenotypical Transformation of Cancer Cells
    Wawruszak, Anna
    Kalafut, Joanna
    Okon, Estera
    Czapinski, Jakub
    Halasa, Marta
    Przybyszewska, Alicja
    Miziak, Paulina
    Okla, Karolina
    Rivero-Muller, Adolfo
    Stepulak, Andrzej
    CANCERS, 2019, 11 (02):
  • [47] Histone Deacetylase Inhibitors Increase Markers of the Dedifferentiated Cancer Stem Cell Phenotype in Human Breast Cancer Cells
    Debeb, B. G.
    Xu, W.
    Lacerda, L.
    Hortobagyi, G. N.
    Robertson, F.
    Ueno, N. N.
    Lucci, A.
    Reuben, J. M.
    Buchholz, T. A.
    Woodward, W. A.
    CANCER RESEARCH, 2010, 70
  • [48] Histone deacetylase inhibitors providing an epigenetic treatment in cancer
    Cinek, Tugce
    Karali, Nilgun
    ISTANBUL JOURNAL OF PHARMACY, 2021, 51 (02): : 283 - 290
  • [49] Novel histone deacetylase inhibitors in the treatment of thyroid cancer
    Mitsiades, CS
    Poulaki, V
    McMullan, C
    Negri, J
    Fanourakis, G
    Goudopoulou, A
    Richon, VM
    Marks, PA
    Mitsiades, N
    CLINICAL CANCER RESEARCH, 2005, 11 (10) : 3958 - 3965
  • [50] Role of histone deacetylase inhibitors in the treatment of cancer (Review)
    Mei, SP
    Ho, AD
    Mahlknecht, U
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2004, 25 (06) : 1509 - 1519
12345